Cyclization of PLP 139-151 peptide reduces its encephalitogenic potential in experimental autoimmune encephalomyelitis
Download
Ep37224_CyclicPLPv5copy.pdf
- Accepted Version
(805kB)
| Preview
Available under license: Creative Commons Attribution Non-commercial No Derivatives
Export
Lourbopoulos, A, Matsoukas, MT, Katsara, M, Deraos, G, Giannakopoulou, A, Lagoudaki, R, Grigoriadis, N, Matsoukas, J and Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771 (2018) Cyclization of PLP 139-151 peptide reduces its encephalitogenic potential in experimental autoimmune encephalomyelitis. Bioorganic and Medicinal Chemistry, 26 (9). 2221 - 2228. ISSN 0968-0896
Dimensions Badge
Altmetric Badge
Item type | Article |
URI | https://vuir.vu.edu.au/id/eprint/37224 |
DOI | 10.1016/j.bmc.2017.12.024 |
Official URL | https://www.sciencedirect.com/science/article/pii/... |
Subjects | Historical > FOR Classification > 1107 Immunology Historical > FOR Classification > 1116 Medical Physiology Historical > Faculty/School/Research Centre/Department > Centre for Chronic Disease Prevention and Management Current > Division/Research > College of Health and Biomedicine |
Keywords | cPLP analog; EAE; peptides; cyclic PLP |
Citations in Scopus | 9 - View on Scopus |
Download/View statistics | View download statistics for this item |
CORE (COnnecting REpositories)